VISTAGEN THERAPEUTICS, INC. Proceeds from Issuance of Warrants
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Proceeds from Issuance of Warrants of $1.04 million for the 163-month period ending 2011-12-31, per its 10-Q filed 2012-02-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2012-02-14
- 2011-12-31: Proceeds from Issuance of Warrants 9 month $1.04M; Proceeds from Issuance of Warrants 163 month $1.04M.
- 2010-12-31: Proceeds from Issuance of Warrants 9 month $0.00.
| Period end | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 163 month |
|---|---|---|
| 2011-12-31 | $1.04M 10-Q · filed 2012-02-14 | $1.04M 10-Q · filed 2012-02-14 |
| 2010-12-31 | $0.00 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |